NEXGEL (NASDAQ:NXGL) Releases Quarterly Earnings Results, Beats Estimates By $0.02 EPS

NEXGEL (NASDAQ:NXGL) announced its quarterly earnings data on Monday. The company reported ($0.08) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.10) by $0.02, Zacks reports. NEXGEL had a negative net margin of 52.60% and a negative return on equity of 71.19%. The business had revenue of $3.04 million during the quarter, compared to the consensus estimate of $2.99 million.

NEXGEL Stock Down 1.9 %

Shares of NEXGEL stock opened at $3.03 on Wednesday. The stock has a market capitalization of $20.58 million, a price-to-earnings ratio of -5.22 and a beta of 0.62. NEXGEL has a twelve month low of $1.84 and a twelve month high of $5.10. The company has a current ratio of 1.51, a quick ratio of 0.93 and a debt-to-equity ratio of 0.19. The business’s 50 day simple moving average is $3.22 and its 200-day simple moving average is $3.27.

NEXGEL Company Profile

NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.